TYPE II DIABETES MELLITUS
Clinical trials for TYPE II DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new TYPE II DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for TYPE II DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New diabetes drug CX11 aims to tame blood sugar in phase 2 trial
Disease control Recruiting nowThis study tests a new medication, CX11, in 240 adults with type 2 diabetes whose blood sugar is not well-controlled despite taking metformin. Participants are randomly assigned to receive different doses of CX11 or a placebo pill for 24 weeks. The main goal is to see if CX11 saf…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
Fetal stem cells tested to tame type 2 diabetes
Disease control Recruiting nowThis study tests a new stem cell treatment made from fetal cells for people with type 2 diabetes. The goal is to see if it is safe and helps control blood sugar better than standard care. About 30 adults with poorly controlled diabetes will receive the therapy and be followed for…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Grocery store nudges aim to boost whole grain choices for diabetes patients
Disease control Recruiting nowThis study tests whether personalized marketing and discounts in an online grocery store can encourage people with prediabetes or type 2 diabetes to buy more whole grains instead of refined grains. About 216 adults aged 45-70 from Pennsylvania who already shop online for grocerie…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New weekly shot shows promise for diabetes and weight loss in phase 2 trial
Disease control Recruiting nowThis study tests a new weekly injection called GL0034 in 285 adults with type 2 diabetes who are overweight or obese. Participants will receive either the study drug or a placebo for about 36 weeks to see if it safely lowers blood sugar levels. The goal is to find a new treatment…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New diabetes drug study aims to improve blood sugar control safely
Disease control Recruiting nowThis study looks at how safe and effective the drug empagliflozin (taken with or without metformin) is for adults with type 2 diabetes. About 156 participants in Pakistan will take the drug and be monitored for side effects and blood sugar changes over 6 months. The goal is to se…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: PHASE4 • Sponsor: Getz Pharma • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Village groups take on diabetes: a new hope for rural pakistan
Prevention Recruiting nowThis study tests whether community-led discussion groups can help prevent and control type 2 diabetes in rural areas of Pakistan. Over 12,000 adults aged 20 and older will participate, including those with normal blood sugar, pre-diabetes, or diabetes. The approach focuses on gro…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: NA • Sponsor: Khyber Medical University Peshawar • Aim: Prevention
Last updated May 15, 2026 11:57 UTC
-
Village meetings aim to curb diabetes in rural kabul
Prevention Recruiting nowThis study tests whether a community-led discussion program can help prevent and control type 2 diabetes in rural Kabul, Afghanistan. About 250 adults aged 20 and older will join group meetings to learn about diabetes risks and healthy habits. The goal is to see if this approach …
Matched conditions: TYPE II DIABETES MELLITUS
Phase: NA • Sponsor: HealthNet Transcultural Psychosocial Organization • Aim: Prevention
Last updated May 14, 2026 12:04 UTC
-
Kidney patients needed for diabetes drug study
Knowledge-focused Recruiting nowThis study looks at how different levels of kidney function affect the way the body handles a new long-acting diabetes drug called GL0034. About 40 adults with type 2 diabetes and various kidney health levels will receive a single injection. Researchers will measure drug levels i…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: PHASE1 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Knowledge-focused
Last updated May 17, 2026 00:47 UTC